To evaluate the effect of surgery on severely impaired pulmonary funct
ion associated with mitral valve disease, we examined the relationship
between postoperative improvements in pulmonary function and pulmonar
y circulation in 238 patients who underwent mitral valve surgery. Of t
hese patients 17 met the preoperative criteria for severely impaired p
ulmonary function: forced expiratory volume in 1 second = FEV1 less-th
an-or-equal-to 1000 ml. They showed average values for vital capacity
(VC) of 1343 +/- 203 ml, for % of vital capacity for predicted values
(%VC) of 52.0 +/- 6.5 %, and for FEV1 of 851 +/- 104 ml. Moderate elev
ations of mean pulmonary arterial pressure (PAP: 36.2 +/- 10.2 mmHg),
mean pulmonary arterial wedge pressure (PAWP: 23.0 +/- 9.6 mmHg), and
pulmonary vascular resistance (PVR: 329 +/- 147 dyne . sec . cm-5) wer
e also observed. Postoperatively, 4 of the 17 patients required long-t
erm respiratory support for more than one week, and 3 patients died in
hospital; this mortality rate, however, was not significantly differe
nt to that of patients with preoperative FEV1 > 1000 ml. In long-survi
ving patients, pulmonary function improved in the late postoperative p
eriod. Significant relationships were recognized between DELTAFEV1 (DE
LTA: postoperative value - preoperative value) and DELTAPAP, DELTAPAWP
, and DELTAPVR. The DELTAVC and DELTA%VC also correlated significantly
with DELTAPAP, DELTAPAWP and DELTAPVR. In conclusion, in patients wit
h mitral valve disease impaired pulmonary function cannot be used to e
xclude patients from operation. Furthermore, severely impaired pulmona
ry function should improve with the improvement of pulmonary circulati
on after surgery.